National Expert Group on Vaccine Administration for COVID-19

Last updated
National Expert Group on Vaccine Administration for COVID-19
Legal statusActive
  • India
Region served
LeaderV. K. Paul

National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) is an expert committee constituted by the Ministry of Health and Family Welfare (MoHFW), India to provide advice and guidance on all aspects of COVID-19 vaccination. The committee is also responsible for prioritisation of population groups in the country, deciding procurement and inventory management procedure, selection and delivery of vaccines etc. [1]


NEGVAC was constituted in mid-2020 and first met on 12 August 2020. [2] [3] [4] is chaired by member (Health), NITI Aayog, and co-chaired by the secretary of MoHFW. The committee has representative secretaries from: [1]

Related Research Articles

Medicines and Healthcare products Regulatory Agency

The Medicines and Healthcare products Regulatory Agency (MHRA) is an executive agency of the Department of Health and Social Care in the United Kingdom which is responsible for ensuring that medicines and medical devices work and are acceptably safe.

The Joint Committee on Vaccination and Immunisation (JCVI) is an independent expert advisory committee that advises United Kingdom health departments on immunisation, making recommendations concerning vaccination schedules and vaccine safety. It has a statutory role in England and Wales, and health departments in Scotland and Northern Ireland may choose to accept its advice.

Crown Agents Ltd is a not-for-profit international development company with head office in London, United Kingdom, and subsidiaries in USA and Japan. The company is working in partnership with ministries, governments, institutions, donors, foundations, philanthropists and the private sector to tackle complex challenges, ranging from procuring and delivering COVID-19 vaccines to hard to reach locations to delivering essential health services to the population of South Sudan. Crown Agents operates worldwide; the company's areas of expertise are: Supply Chain and Inspections; Institutional Efficiency, Programme Design, Delivery and Evaluation, Project and Fund Management, and Training and Professional Development.

Mission Indradhanush

Mission Indradhanush is a health mission of the Government of India. It was launched by Union Health Minister J. P. Nadda on 25 December 2014. The scheme this seeks to drive towards 90% full immunisation coverage of India and sustain the same by year 2020. Vaccination is being provided against eight vaccine-preventable diseases nationally, i.e. Diphtheria, Whooping Cough, Tetanus, Polio, Measles, severe form of Childhood Tuberculosis and Hepatitis B and meningitis & pneumonia caused by Haemophilus influenza type B; and against Rotavirus Diarrhea and Japanese Encephalitis in selected states and districts respectively.

The Viral Research and Diagnostic Laboratories (VRDL) scheme was introduced by the Government of India under Department of Health Research - Indian Council of Medical Research as outbreaks of viral agents is very common in India. The Central government announced the establishment of 166 research and diagnostics laboratories in 2016. By 2019, 103 new VRDLs were established across India, taking the total count to 105.

Soumya Swaminathan Indian and WHO Deputy Director general

Soumya Swaminathan Yadav is an Indian paediatrician and clinical scientist known for her research on tuberculosis and HIV. Since March 2019, Swaminathan has served as the Chief Scientist at the World Health Organization. Previously, from October 2017 to March 2019, she was the Deputy Director General of Programmes (DDP) at the World Health Organization.

Vinod Kumar Paul Indian pediatrician

Dr. Vinod Kumar Paul is an Indian pediatrician and physician scientist currently serving as Member, NITI Aayog. He earlier served as Professor of Neonatology at the Department of Pediatrics, All India Institute of Medical Sciences (AIIMS), New Delhi from 1985 to 2020. He is associated with India's health policy as well as child and maternal health programs..

Preeti Sudan is a retired Indian bureaucrat who served as Health Secretary of India from October 2017 to July 2020. She has been the key strategist in times of the COVID-19 pandemic.

COVID-19 pandemic in India Ongoing COVID-19 viral pandemic in India

The COVID-19 pandemic in India is part of the worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. The first case of COVID-19 in India, which originated from China, was reported on 30 January 2020. India currently has the largest number of confirmed cases in Asia. As of May 2021, India has the second-highest number of confirmed cases in the world with 25.4 million reported cases of COVID-19 infection and 283,248 deaths as of 19 May 2021.

COVID-19 pandemic in Madhya Pradesh Ongoing COVID-19 viral pandemic in Madhya Pradesh, India

The first cases of the COVID-19 pandemic in Madhya Pradesh were confirmed on March 20, 2020. These were the first four cases in Jabalpur, Madhya Pradesh. Madhya Pradesh has confirmed a total of 588 thousand cases, including 5812 deaths and 495 thousand recoveries, as of the 3rd of May, 2021.

The first case of the COVID-19 pandemic in India was reported on 30 January 2020, originating from China. Slowly, the pandemic spread to various states and union territories including the state of Telangana. The first case was recorded in this region on 2 March from a man who had travel history with the UAE.

The first case of the COVID-19 pandemic in India was reported on 30 January 2020. Slowly, the pandemic spread to various states and union territories including the state of Uttarakhand. The first case was recorded in this region on 15 March.

The first case of COVID-19 on the Union Territory of Lakshadweep was recorded on 18 January 2021. Lakshadweep Islands, until then, was India's only COVID-free territory (state/UT), and life was pretty normal for the residents of the UT.

The COVID-19 pandemic reached the state of Nagaland on 22 May 2020, with its first case confirmed on 25 May 2020. Officially, Nagaland is the last of the northeastern states after Sikkim to report COVID-19 positive cases.

Nikki Turner (public health advocate) New Zealand vaccinologist and medical practitioner

Nicola Mary Turner is a New Zealand public health advocate who is a professor of General Practice at the University of Auckland and Director of the Immunisation Advisory Centre, the organisation that advises the New Zealand Medical profession and the New Zealand government. She has contributed to advisory committees for the New Zealand Ministry of Health and is a spokesperson for the NZ Child Poverty Action Group. Much of her research and outreach has focused on improving immunisation coverage and closing equity gaps for the national schedule vaccine delivery in New Zealand. Since 2011 Turner has been part of the General Practice team at Newtown Union Health Services (NUHS), Broadway, Wellington.

The Vaccine Taskforce in the United Kingdom of Great Britain and Northern Ireland was set up in May 2020 by the Second Johnson ministry, in collaboration with Chief Scientific Advisor Patrick Vallance and Chief Medical Officer Professor Chris Whitty, in order to facilitate the path towards the introduction of a COVID-19 vaccine in the UK and its global distribution. The taskforce acts to coordinate the research efforts of government with industry, academics and funding agencies in order to be able to make timely decisions which expedite vaccine development and deployment.

COVID-19 vaccination in the United Kingdom Plan to immunize against COVID-19

The COVID-19 vaccination programme in the United Kingdom is the world's first mass immunisation campaign to protect against SARS-CoV-2 using vaccines developed in response to the COVID-19 pandemic.

COVID-19 vaccination in the Philippines Plan to immunize against COVID-19

The COVID-19 vaccination program in the Philippines is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in India Immunisation programme against COVID-19 in India

India began administration of COVID-19 vaccines on 16 January 2021. As of 21 May 2021, India has administered 193,372,819 doses overall, including first and second doses of the currently-approved vaccines.

COVID-19 vaccination in Canada COVID-19 vaccination programme in Canada

The COVID-19 vaccination programme in Canada is an ongoing, intergovernmental effort coordinated between the bodies responsible in the Government of Canada to acquire and distribute vaccines to individual provincial and territorial governments who in turn administer approved COVID-19 vaccines during the COVID-19 pandemic in Canada. Some provinces have asked local municipal governments, hospital systems, family doctors and independently owned pharmacies to aid in part, or in full with vaccination rollout. The vaccination effort in full is the largest such immunization effort in the nation's history. With Health Canada approving the Pfizer–BioNTech COVID-19 vaccine on December 9, 2020, mass vaccination efforts began across the country on December 14, 2020. The agency later approved the mRNA-1273 vaccine developed by Moderna on December 23, 2020.


  1. 1 2 "High Level Committee for Distribution and Administration of COVID-19 Vaccines". Retrieved 19 May 2021.
  2. Das, Sohini (2020-08-17). "National Expert Group meets Covid-19 vaccine makers to discuss road ahead". Business Standard India. Retrieved 19 May 2021.
  3. 1 2 "National Expert Group on Vaccine Administration for COVID-19 deliberates on strategy to ensure COVID-19 vaccines' availability and its delivery mechanism". Retrieved 19 May 2021.
  4. "National Expert Group On Vaccine Administration Working On Management Of COVID-19 Vaccine Roll-Out: Government | News". NDTV-Dettol Banega Swasth Swachh India. 2020-12-09. Retrieved 19 May 2021.